130 related articles for article (PubMed ID: 10656788)
1. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae.
Parissi V; Caumont AB; de Soultrait VR; Calmels C; Pichuantes S; Litvak S; Dupont CH
J Mol Biol; 2000 Jan; 295(4):755-65. PubMed ID: 10656788
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.
Calmels C; de Soultrait VR; Caumont A; Desjobert C; Faure A; Fournier M; Tarrago-Litvak L; Parissi V
Nucleic Acids Res; 2004; 32(4):1527-38. PubMed ID: 14999095
[TBL] [Abstract][Full Text] [Related]
3. A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.
de Soultrait VR; Caumont A; Parissi V; Morellet N; Ventura M; Lenoir C; Litvak S; Fournier M; Roques B
J Mol Biol; 2002 Apr; 318(1):45-58. PubMed ID: 12054767
[TBL] [Abstract][Full Text] [Related]
4. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60.
Parissi V; Calmels C; De Soultrait VR; Caumont A; Fournier M; Chaignepain S; Litvak S
J Virol; 2001 Dec; 75(23):11344-53. PubMed ID: 11689615
[TBL] [Abstract][Full Text] [Related]
6. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
7. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
Biopolymers; 2010 Aug; 93(8):740-51. PubMed ID: 20517955
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication.
Xu Z; Zheng Y; Ao Z; Clement M; Mouland AJ; Kalpana GV; Belhumeur P; Cohen EA; Yao X
Retrovirology; 2008 Nov; 5():102. PubMed ID: 19014595
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins.
Van Maele B; Debyser Z
AIDS Rev; 2005; 7(1):26-43. PubMed ID: 15875659
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 integrase crosslinked oligomers are active in vitro.
Faure A; Calmels C; Desjobert C; Castroviejo M; Caumont-Sarcos A; Tarrago-Litvak L; Litvak S; Parissi V
Nucleic Acids Res; 2005; 33(3):977-86. PubMed ID: 15718297
[TBL] [Abstract][Full Text] [Related]
12. Analysis of conserved and non-conserved amino acids critical for ALSV (Avian leukemia and sarcoma viruses) integrase functions in vitro.
Moreau K; Faure C; Verdier G; Ronfort C
Arch Virol; 2002 Sep; 147(9):1761-78. PubMed ID: 12209315
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51.
Desfarges S; San Filippo J; Fournier M; Calmels C; Caumont-Sarcos A; Litvak S; Sung P; Parissi V
Nucleic Acids Res; 2006; 34(21):6215-24. PubMed ID: 17090598
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
Gleenberg IO; Herschhorn A; Hizi A
J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
Middleton T; Lim HB; Montgomery D; Rockway T; Tang H; Cheng X; Lu L; Mo H; Kohlbrenner WE; Molla A; Kati WM
Antiviral Res; 2004 Oct; 64(1):35-45. PubMed ID: 15451177
[TBL] [Abstract][Full Text] [Related]
16. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
Greenwald J; Le V; Butler SL; Bushman FD; Choe S
Biochemistry; 1999 Jul; 38(28):8892-8. PubMed ID: 10413462
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the activity of HIV-1 integrase over-expressed in eukaryotic cells.
Van Maele B; Van Eylen L; Pluymers W; Debyser Z
Biochem Biophys Res Commun; 2005 Feb; 327(1):261-7. PubMed ID: 15629457
[TBL] [Abstract][Full Text] [Related]
18. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
19. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase.
Konsavage WM; Sudol M; Katzman M
Virology; 2008 Sep; 379(2):223-33. PubMed ID: 18687451
[TBL] [Abstract][Full Text] [Related]
20. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
